Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

NCT06223568 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

70

Enrollment

NIH

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck
Oropharynx
Human Papillomavirus Viruses
Drug Therapy
Cancer Vaccine

Interventions

DRUG: Docetaxel
DRUG: Cisplatin
DRUG: PRGN-2009

Sponsor

National Cancer Institute (NCI)